159 related articles for article (PubMed ID: 36326394)
1. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behçet's disease.
Karaaslan Z; Şanlı E; Timirci-Kahraman Ö; Yılmaz V; Akbayır E; Koral G; İçöz S; Gündüz T; Küçükali Cİ; Kürtünvü M; Tüzün E
Turk J Med Sci; 2022 Aug; 52(4):1266-1273. PubMed ID: 36326394
[TBL] [Abstract][Full Text] [Related]
2. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.
Ugurel E; Erdag E; Kucukali CI; Olcay A; Sanli E; Akbayir E; Kurtuncu M; Gunduz T; Yilmaz V; Tuzun E; Vural B
In Vivo; 2019; 33(5):1493-1497. PubMed ID: 31471397
[TBL] [Abstract][Full Text] [Related]
3. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.
Tamam Y; Gunes B; Akbayir E; Kizilay T; Karaaslan Z; Koral G; Duzel B; Kucukali CI; Gunduz T; Kurtuncu M; Yilmaz V; Tuzun E; Turkoglu R
Mult Scler Relat Disord; 2021 Feb; 48():102697. PubMed ID: 33352356
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
5. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
6. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
7. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
9. Myocardial involvement in Behçet's disease may be higher in patients with Neuro-Behçet's disease: a speckle tracking echocardiographic study.
Sunbul M; Midi IG; Agackiran SK; Engin E; Ucem S; Alibaz-Oner F; Sayar N; Direskeneli H; Sadıc BO
Acta Cardiol; 2022 Aug; 77(6):515-523. PubMed ID: 34392811
[TBL] [Abstract][Full Text] [Related]
10. Myelin basic protein and index for neuro-Behçet's disease.
Zhan H; Cheng L; Wang X; Jin H; Liu Y; Li H; Liu D; Zhang X; Zheng W; Hao H; Li Y
Clin Immunol; 2023 May; 250():109286. PubMed ID: 36907539
[TBL] [Abstract][Full Text] [Related]
11. Parenchymal Neuro-Behçet's disease or Comorbid Behçet's disease with multiple sclerosis: A discriminative analysis of a complex clinical entity.
İsmayılov R; Talibov T; Gündüz T; Kürtüncü M
Mult Scler Relat Disord; 2024 Jul; 87():105684. PubMed ID: 38788360
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
[TBL] [Abstract][Full Text] [Related]
16. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
17. Nutritional Status in patients with Neuro-Behçet's disease.
Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Radiographic Characteristics of Neuro-Behçet's Disease in South Korea.
Kim SW; Kim TG; Oh J; Kim DY; Choi YC; Kim SM; Shin HY; Bang D
J Clin Neurol; 2019 Oct; 15(4):429-437. PubMed ID: 31591829
[TBL] [Abstract][Full Text] [Related]
19. Significance of immunoglobulins synthesis with central nervous system involvement in Neuro-Behçet's disease.
Zhan H; Cheng L; Liu Y; Xu H; Feng X; Liu Y; Li H; Li Z; Wang S; Jin H; Zheng W; Hao H; Li Y
Clin Chim Acta; 2024 Jun; 559():119681. PubMed ID: 38643816
[TBL] [Abstract][Full Text] [Related]
20. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
